Portfoliotracker

Oaktree Acquisition Corp. III Life Sciences

OACC · NASDAQGM · Financial Services Shell Companies 55/100 C

10,70 $
▲ +0,00 (+0,00 %)
Pre-market delayed by 15 min
Price as of 5. 11. 22:00, fetched 17. 11. 12:23
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score55 / 100 Market cap263 mil. $ P/E38,2 Forward P/E– P/S– P/B– EV/EBITDA– Dividend yield– FCF yield-0,17 % EPS0,28 $ Net margin0,0 % Return on equity– Beta– Debt / equity–
52-week range 10,50 to 10,93
3-month average volume0,0 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Country
United States
Fiscal year end
31. 12.
Data since
16. 12. 2024

Explore further

Similar companies NPACLWACGPATTWLVSDHI

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account